JPH09302034A - Polymeric material which can remove nucleic acid derivative and urea by adsorption - Google Patents
Polymeric material which can remove nucleic acid derivative and urea by adsorptionInfo
- Publication number
- JPH09302034A JPH09302034A JP15596696A JP15596696A JPH09302034A JP H09302034 A JPH09302034 A JP H09302034A JP 15596696 A JP15596696 A JP 15596696A JP 15596696 A JP15596696 A JP 15596696A JP H09302034 A JPH09302034 A JP H09302034A
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- urea
- hydrophilic solvent
- polymeric material
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 32
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 32
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 32
- 239000004202 carbamide Substances 0.000 title claims abstract description 22
- 239000000463 material Substances 0.000 title claims abstract description 12
- 238000001179 sorption measurement Methods 0.000 title description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000002904 solvent Substances 0.000 claims abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 125000002252 acyl group Chemical group 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 5
- 239000002861 polymer material Substances 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 abstract description 22
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 abstract description 8
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 8
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 8
- 239000001257 hydrogen Substances 0.000 abstract description 8
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 8
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 abstract description 8
- 229940116269 uric acid Drugs 0.000 abstract description 8
- 239000012046 mixed solvent Substances 0.000 abstract description 5
- 230000000295 complement effect Effects 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 239000003960 organic solvent Substances 0.000 abstract description 4
- -1 polyethylene Polymers 0.000 abstract description 4
- 229960004559 theobromine Drugs 0.000 abstract description 4
- 229940075420 xanthine Drugs 0.000 abstract description 4
- 239000004698 Polyethylene Substances 0.000 abstract description 2
- 239000004721 Polyphenylene oxide Substances 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000002777 nucleoside Substances 0.000 abstract description 2
- 125000003835 nucleoside group Chemical group 0.000 abstract description 2
- 239000002773 nucleotide Substances 0.000 abstract description 2
- 125000003729 nucleotide group Chemical group 0.000 abstract description 2
- 229920000728 polyester Polymers 0.000 abstract description 2
- 229920000570 polyether Polymers 0.000 abstract description 2
- 229920000573 polyethylene Polymers 0.000 abstract description 2
- 229920001184 polypeptide Polymers 0.000 abstract description 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 2
- 101100294102 Caenorhabditis elegans nhr-2 gene Proteins 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 7
- 239000000178 monomer Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- WEWFIUPOLKEEJP-UHFFFAOYSA-N triazine-4,6-diamine Chemical compound NC1=CC(N)=NN=N1 WEWFIUPOLKEEJP-UHFFFAOYSA-N 0.000 description 3
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229940104230 thymidine Drugs 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
- 229940045145 uridine Drugs 0.000 description 2
- ZWKNLRXFUTWSOY-QPJJXVBHSA-N (e)-3-phenylprop-2-enenitrile Chemical compound N#C\C=C\C1=CC=CC=C1 ZWKNLRXFUTWSOY-QPJJXVBHSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- XUDBVJCTLZTSDC-UHFFFAOYSA-N 2-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C=C XUDBVJCTLZTSDC-UHFFFAOYSA-N 0.000 description 1
- UWRZIZXBOLBCON-UHFFFAOYSA-N 2-phenylethenamine Chemical compound NC=CC1=CC=CC=C1 UWRZIZXBOLBCON-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000012690 ionic polymerization Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- ZDAZUJBASMCUAK-UHFFFAOYSA-N n-[2-(1h-indol-3-yl)ethyl]pyridine-3-carboxamide Chemical compound C=1NC2=CC=CC=C2C=1CCNC(=O)C1=CC=CN=C1 ZDAZUJBASMCUAK-UHFFFAOYSA-N 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Polyamides (AREA)
- Polyethers (AREA)
- Polyesters Or Polycarbonates (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、親水性溶媒系から核酸
誘導体および尿素を効率的に吸着除去する高分子材料に
関するものである。FIELD OF THE INVENTION The present invention relates to a polymeric material capable of efficiently adsorbing and removing a nucleic acid derivative and urea from a hydrophilic solvent system.
【0002】[0002]
【従来の技術】核酸誘導体および尿素は代謝系の最終生
成物の一つとして血液中に存在し、最終的に尿として体
外に排出されるが、腎機能に支障を来し核酸誘導体が過
剰に血液中に存在すると様々な疾病の原因となる。例え
ば核酸誘導体の一種である尿酸は高尿酸血症および通風
を引き起こす。このように核酸誘導体および尿素を選択
的に除去する技術の開発は医学的に重要であり、特に腎
臓障害者の透析治療では、尿素および尿酸に代表される
様な核酸誘導体を体外に除去する必要があった。従来の
透析治療に用いられた中空糸は微細な細孔を有するセル
ロース系の繊維が主であり、血中で不要となる物質は上
記細孔により分子の大きさを“ふるい”にかけることで
行われていた。すなわち素材自身に核酸誘導体に対する
認識能力が備わっていないため、分離効率が悪く、透析
治療には大がかりな透析装置と長時間が必要であった。Nucleic acid derivatives and urea are present in the blood as one of the final products of the metabolic system, and are eventually excreted as urine from the body. When present in blood, it causes various diseases. For example, uric acid, a type of nucleic acid derivative, causes hyperuricemia and gout. Thus, the development of a technique for selectively removing nucleic acid derivatives and urea is medically important, and it is particularly necessary to remove nucleic acid derivatives such as urea and uric acid from the body in dialysis treatment of patients with renal impairment. was there. The hollow fibers used for conventional dialysis treatment are mainly cellulosic fibers with fine pores, and substances unnecessary in the blood can be filtered by sieving the molecular size through the above pores. It was done. That is, since the material itself does not have the ability to recognize nucleic acid derivatives, the separation efficiency is poor, and a dialysis treatment requires a large-scale dialysis machine and a long time.
【0003】一方、これら核酸誘導体をはじめとする生
体関連物質と水素結合により選択的に結合・認識する試
みが数多くなされてきた。レベクらの「ジャーナル、オ
ブ、アメリカン、ケミカル、ソサエティ」(Journ
al of American Chemical S
ociety)誌、1991年第113巻5125頁に
記載された化合物は、上記水素結合により核酸誘導体を
結合・認識する試みの一環として合成されたものである
が、そのほとんどはクロロホルムなどの非極性溶媒中で
あり、水溶液中で水素結合により核酸誘導体および尿素
を効率的に除去するものではなかった。ハミルトンらに
よる「ジャーナル、オブ、アメリカン、ケミカル、ソサ
エティ」(Journal of American
ChemicalSociety)誌、1993年第1
15巻369頁記載の化合物は、有機溶媒と水の混合溶
液中でも有機分子を認識することが可能であることが記
されているが、該有機溶媒の比率が低い溶媒系では認識
能がほとんどなくなる。そこで親水性溶媒中で効率的に
核酸誘導体を結合・認識し高分子材料の開発が望まれて
いた。On the other hand, many attempts have been made to selectively bind and recognize biologically relevant substances such as these nucleic acid derivatives by hydrogen bonds. Rebek et al., "Journal, Of, American, Chemical, Society" (Journ
al of American Chemical S
The compounds described in Journal of the Society, Vol. 113, p. 5125, 1991 were synthesized as part of an attempt to bind and recognize a nucleic acid derivative by the above hydrogen bond, but most of them are nonpolar solvents such as chloroform. However, it did not efficiently remove the nucleic acid derivative and urea by hydrogen bonding in an aqueous solution. Hamilton et al., "Journal of American, Chemical, Society" (Journal of American)
Chemical Society, 1st 1993.
It is described that the compound described in Vol. 15, page 369 is capable of recognizing organic molecules even in a mixed solution of an organic solvent and water, but in a solvent system having a low ratio of the organic solvent, the recognition ability is almost lost. . Therefore, it has been desired to develop a polymer material capable of efficiently binding and recognizing a nucleic acid derivative in a hydrophilic solvent.
【0004】[0004]
【発明が解決しようとする課題】本発明の課題は、核酸
誘導体および尿素を親水性溶媒中で効率的に除去する高
分子材料を得ることである。An object of the present invention is to obtain a polymeric material capable of efficiently removing a nucleic acid derivative and urea in a hydrophilic solvent.
【0005】[0005]
【課題を解決するための手段】上記課題は、核酸誘導体
および尿素を親水性溶媒中で吸着除去可能な高分子材料
において、該高分子材料が式(1)に示すような残基を
有することを特徴とする高分子材料により達成された。 ここで X1、X2=N、CH Y=H、NHR2 R1、R2=H、アルキル基、フェニル基、アシル基 を示す。[Means for Solving the Problems] The above object is to provide a polymeric material capable of adsorbing and removing a nucleic acid derivative and urea in a hydrophilic solvent, wherein the polymeric material has a residue represented by the formula (1). Was achieved by a polymeric material characterized by: Here, X 1 , X 2 = N, CH Y = H, NHR 2 R 1 , R 2 = H, an alkyl group, a phenyl group, and an acyl group are shown.
【0006】ここで言う核酸誘導体とは、DNAあるい
はRNAを構成しているヌクレオチド、ヌクレオシドお
よび核酸塩基、そして尿酸、キサンチン、テオブロミン
を示す。これらの核酸誘導体は、図1に示すような相補
的な水素結合を親水性溶媒中で形成することにより、高
分子中に取り込まれる。従って、該式1中の官能基は、
除去する核酸誘導体と水素結合様式が相補的になるよう
に適宜選択すればよい。例えば、ウラシル、ウリジン、
チミン、チミジン、尿酸、キサンチン、テオブロミンの
様に、相補的水素結合対が3つ存在する場合は、Y=N
HR2が好ましい。水素結合対形成のためにはそれぞれ
の結合において水素原子が一つ存在すればよいので
R1、R2はどのような官能基でもよいが、好ましくは
H、アルキル基、フェニル基、アシル基、より好ましく
はHである。一方アデニンあるいはアデノシンの様に2
つの水素結合能を有する場合は、好ましくはY=Hであ
る。The term "nucleic acid derivative" as used herein refers to nucleotides, nucleosides and nucleobases constituting DNA or RNA, and uric acid, xanthine and theobromine. These nucleic acid derivatives are incorporated into a polymer by forming complementary hydrogen bonds as shown in FIG. 1 in a hydrophilic solvent. Therefore, the functional group in Formula 1 is
It may be appropriately selected so that the nucleic acid derivative to be removed is complementary in hydrogen bonding mode. For example, uracil, uridine,
When there are three complementary hydrogen bond pairs such as thymine, thymidine, uric acid, xanthine and theobromine, Y = N
HR 2 is preferred. R 1 and R 2 may be any functional groups, since one hydrogen atom may be present in each bond for forming a hydrogen bond pair, but preferably H, an alkyl group, a phenyl group, an acyl group, It is more preferably H. On the other hand, like adenine or adenosine, 2
When it has two hydrogen-bonding capacities, Y = H is preferable.
【0007】図1FIG. 1
【0008】本発明の親水性溶媒とは、水または水と体
積比で1:1の割合で混合可能な有機溶媒のことで、例
えば、メタノール、エタノール、プロパノール、ブタノ
ール、アセトニトリル、テトラヒドロフラン、ジメチル
スルホキシド、ジメチルホルムアミド等を示す。これら
の溶媒の混合比は任意でよく、二種類以上の溶媒を混合
してもかまわない。上記で挙げた溶媒の内、好ましく
は、水、メタノール、エタノールまたはこれらの混合溶
媒である。The hydrophilic solvent of the present invention means water or an organic solvent which can be mixed with water in a volume ratio of 1: 1, and examples thereof include methanol, ethanol, propanol, butanol, acetonitrile, tetrahydrofuran and dimethyl sulfoxide. , Dimethylformamide and the like. The mixing ratio of these solvents may be arbitrary, and two or more kinds of solvents may be mixed. Of the above-mentioned solvents, water, methanol, ethanol or a mixed solvent thereof is preferable.
【0009】以下、本発明を詳細に記す。本発明の高分
子材料は、式1に示すような残基が高分子主鎖中の側鎖
に共有結合で導入されていることが望ましい。主鎖はポ
リエチレン、ポリペプチド、ポリエステル、ポリエーテ
ル、いずれでも良い。また、主鎖に式1の残基が直接つ
ながっていても、主鎖と該残基の間にスペーサーが存在
しても良い。スペーサーとしては、−(CH2)n−、
−(C6H4)−、−CONH−、−COO−、−CO
O−(CH2)n−、−(C6H4)−(CH2)
n−、−COO−(CH2)n−、−CONH−(CH
2)n−、などが挙げられるが、これらに限られるもの
ではない。式1の芳香族環は、ピリジン環(X1=X2
=CH)、ピリミジン環(X1=CH、X2=N、また
はX1=N、X2=CH)、トリアジン環(X1=X2
=N)いずれでも良い。合成法に応じて適宜選択するこ
とが可能である。また式1の残基が高分子中に含まれて
いれば、別の残基が同一高分子中に導入されていてもか
まわない。すなわち、式1を含むモノマーと別のモノマ
ーを共重合させても良い。共重合に用いるモノマーとし
ては、スチレン、アクリルアミド、アミノスチレン、酢
酸ビニル、ビニル安息香酸、アクリル酸メチル、メタク
リル酸メチル、シアノスチレン、アクリル酸、メチルス
チレン、アクリル酸トリプタミド、アクリル酸ナフチル
エチル、アクリロニトリル、などを挙げることができ
る。The present invention will be described in detail below. In the polymer material of the present invention, it is desirable that the residue represented by Formula 1 be introduced into the side chain of the polymer main chain by a covalent bond. The main chain may be polyethylene, polypeptide, polyester, or polyether. Further, the residue of Formula 1 may be directly linked to the main chain, or a spacer may be present between the main chain and the residue. The spacer, - (CH 2) n - ,
- (C 6 H 4) - , - CONH -, - COO -, - CO
O- (CH 2) n -, - (C 6 H 4) - (CH 2)
n -, - COO- (CH 2 ) n -, - CONH- (CH
2 ) n −, and the like, but are not limited thereto. The aromatic ring of Formula 1 is a pyridine ring (X 1 = X 2
= CH), a pyrimidine ring (X 1 = CH, X 2 = N, or X 1 = N, X 2 = CH), a triazine ring (X 1 = X 2)
= N) Either may be used. It can be appropriately selected depending on the synthesis method. If the residue of Formula 1 is contained in the polymer, another residue may be introduced into the same polymer. That is, a monomer containing Formula 1 and another monomer may be copolymerized. As the monomer used for the copolymerization, styrene, acrylamide, aminostyrene, vinyl acetate, vinyl benzoic acid, methyl acrylate, methyl methacrylate, cyanostyrene, acrylic acid, methylstyrene, tryptamide acrylate, naphthylethyl acrylate, acrylonitrile, And so on.
【0010】以下に本発明の好ましい使用形態を示す。 (1)核酸誘導体および尿素を親水性溶媒中で吸着除去
可能な高分子材料において、該高分子材料が式1に示す
ような残基を有することを特徴とする高分子材料 ここで X1、X2=N、CH Y=H、NHR2 R1、R2=H、アルキル基、フェニル基、アシル基 を示す。 (2) 該式1においてR1=R2=Hであることを特
徴とする(1)記載の高分子材料。 (3) 該核酸誘導体がウラシル、ウリジン、チミン、
チミジン、尿酸、キサンチン、テオブロミンである場
合、YがNH2であることを特徴とする(2)記載の高
分子材料。 (4) 該親水性溶媒が、水、メタノールおよびエタノ
ールであることを特徴とする(1)から(3)記載の高
分子材料 (5) 該親水性溶媒が、水、水とメタノールの混合溶
媒、または水とエタノールの混合溶媒であることを特徴
とする(4)記載の高分子材料 (6) (5)における水または該混合溶媒のpHが4
から9の間で用いられることを特徴とする(5)記載の
高分子材料。The preferred usage forms of the present invention are shown below. (1) A polymer material capable of adsorbing and removing a nucleic acid derivative and urea in a hydrophilic solvent, wherein the polymer material has a residue as shown in Formula 1. Here, X 1 , X 2 = N, CH Y = H, NHR 2 R 1 , R 2 = H, an alkyl group, a phenyl group, and an acyl group are shown. (2) The polymer material according to (1), wherein R 1 = R 2 = H in the formula 1 . (3) The nucleic acid derivative is uracil, uridine, thymine,
In the case of thymidine, uric acid, xanthine or theobromine, Y is NH 2 , and the polymer material according to (2). (4) The polymer material according to (1) to (3), wherein the hydrophilic solvent is water, methanol and ethanol (5) The hydrophilic solvent is water, or a mixed solvent of water and methanol Or a mixed solvent of water and ethanol, wherein the polymer material according to (4) has a pH of 4 in the water or the mixed solvent in (5).
The polymer material according to (5), characterized in that it is used between 1 and 9.
【0011】式1の残基の高分子主鎖への導入は高分子
反応でも良いし、対応するモノマーを合成して重合する
ことも可能である。また、目的とする機能に応じて様々
なモノマーと共重合することができる。例えば野口らに
よる「有機合成化学」誌1996年第24巻第2号12
5頁記載の方法により、−CN基を導入した後にグアニ
ジンと塩基性下で反応させることにより、ジアミノトリ
アジンを導入することができる。また、「ジャーナル、
オブ、アメリカン、ケミカル、ソサエティ」(Jour
nal of American Chemical
Society)誌、1957年第79巻941頁に記
載の方法によりあらかじめトリアジン環を含むビニルモ
ノマーを合成し、これをラジカル重合あるいはイオン重
合等の方法で重合させることができる。得られた高分子
材料は、いずれのpHで用いることも可能であるが、好
ましくは2から10、より好ましくは4から9の間であ
る。The introduction of the residue of formula 1 into the polymer main chain may be carried out by a polymer reaction, or the corresponding monomer may be synthesized and polymerized. Further, it can be copolymerized with various monomers depending on the intended function. For example, Noguchi et al., "Organic Synthetic Chemistry", 1996, Vol.
By the method described on page 5, a diaminotriazine can be introduced by introducing a —CN group and then reacting with guanidine under basic conditions. Also, "Journal,
Of, American, Chemical, Society "(Jour
nal of American Chemical
The vinyl monomer containing a triazine ring can be previously synthesized by the method described in Sociity), Vol. 79, page 941, 1957, and this can be polymerized by a method such as radical polymerization or ionic polymerization. The obtained polymeric material can be used at any pH, but it is preferably 2 to 10, more preferably 4 to 9.
【0012】高分子中に導入する残基として、具体的に
図2のものを挙げることができる。Specific examples of the residue introduced into the polymer are those shown in FIG.
【0013】図2FIG. 2
【0014】[0014]
【実施例】以下に具体例をあげ、本発明をさらに詳しく
説明するが、発明の主旨を越えない限り、本発明は実施
例に限定されるものではない。 [実施例1] 本発明の高分子の合成 容量が50mlの重合管に、市販の2−ビニル−4,6
−ジアミノ−1,3,5−トリアジン2gおよび重合開
始剤として32mg(?)のアゾビスイソブチロニトリ
ルを添加し、更に溶媒として50mlのジメチルスルホ
キシドを添加し上記試薬を溶解させた後、凍結脱気を3
回繰り返して重合管を真空封管した。これを70℃の湯
浴中で5時間攪拌することで重合させた。重合生成物
は、溶媒のジメチルスルホキシドには不溶のため重合の
進行とともに沈殿として得られた。これを濾過により分
離し、更にジメチルスルホキシド、水、メタノールの順
に多量の溶媒で洗浄した後減圧乾燥することで、本発明
の高分子A(ポリ2−ビニル−4,6−ジアミノ−1,
3,5−トリアジン)を得た。上記高分子Aは、pH4
〜8の間では実質水に対して不溶であった。The present invention will be described in more detail with reference to specific examples, but the present invention is not limited to the examples unless it exceeds the gist of the invention. Example 1 Synthesis of Polymer of the Present Invention A polymerization tube having a capacity of 50 ml was charged with commercially available 2-vinyl-4,6.
-Adding 2 g of diamino-1,3,5-triazine and 32 mg (?) Of azobisisobutyronitrile as a polymerization initiator, and further adding 50 ml of dimethyl sulfoxide as a solvent to dissolve the above-mentioned reagent, followed by freezing. Degas 3
The polymerization tube was vacuum-sealed repeatedly. This was polymerized by stirring in a hot water bath at 70 ° C. for 5 hours. The polymerization product was insoluble in the solvent dimethylsulfoxide, and thus was obtained as a precipitate as the polymerization proceeded. This is separated by filtration, further washed with a large amount of a solvent in the order of dimethylsulfoxide, water and methanol, and then dried under reduced pressure to obtain the polymer A (poly2-vinyl-4,6-diamino-1,
3,5-triazine) was obtained. The polymer A has a pH of 4
It was insoluble in substantial water between -8.
【0015】容量が50mlの重合管に、減圧蒸留で精
製したスチレン11mlとアクリロニトリル4mlを入
れ、溶媒としてジメチルホルムアミドを15ml加え、
更に重合開始剤として50mgのアゾビスイソブチロニ
トリルを添加した後、凍結脱気を3回繰り返して重合管
を真空封管した。これを70℃の湯浴中で5時間攪拌す
ることにより重合させた。この後直ちに温度を下げて重
合を停止させ、多量のメタノール中に上記混合溶液を流
し込むことで得られた白色沈殿を濾過で分離し真空乾燥
した。この共重合体5gを再びジメチルホルムアミド3
0mlに溶解しジシアンジアミド1.7gを加え、更に
触媒として水酸化カリウム0.11gを加え130℃で
1時間攪拌することにより、ジアミノトリアジン環を導
入した。温度を下げて反応を停止した後、再び多量のメ
タノール中に流し込むことで得られた黄白色の沈殿を濾
過し真空乾燥することで本発明の高分子Bを得た。得ら
れたポリマー中に導入されたジアミノトリアジンの量は
1H−NMRから0.37mmol/gであることがわ
かった。A polymerization tube having a volume of 50 ml was charged with 11 ml of styrene purified by vacuum distillation and 4 ml of acrylonitrile, and 15 ml of dimethylformamide was added as a solvent.
Furthermore, after adding 50 mg of azobisisobutyronitrile as a polymerization initiator, freeze deaeration was repeated 3 times to seal the polymerization tube in a vacuum. This was polymerized by stirring in a water bath at 70 ° C. for 5 hours. Immediately thereafter, the temperature was lowered to stop the polymerization, and the white precipitate obtained by pouring the above mixed solution into a large amount of methanol was separated by filtration and vacuum dried. 5 g of this copolymer was again added to dimethylformamide 3
The solution was dissolved in 0 ml, 1.7 g of dicyandiamide was added, 0.11 g of potassium hydroxide was further added as a catalyst, and the mixture was stirred at 130 ° C. for 1 hour to introduce a diaminotriazine ring. After the temperature was lowered to stop the reaction, the mixture was poured into a large amount of methanol again to obtain a yellowish white precipitate, which was filtered and vacuum dried to obtain a polymer B of the present invention. The amount of diaminotriazine introduced into the obtained polymer is
It was found from 1 H-NMR to be 0.37 mmol / g.
【0016】核酸誘導体の分離実験 1.0×10−4mol/リットルの濃度の各種核酸誘
導体の水溶液(pH5〜8)1mlに、得られた高分子
10mgを添加し、時々振とうしながら1時間20℃に
保った。この後ポリマーを遠心分離により除去し、上澄
み液中の残存核酸誘導体濃度を逆相高速液体クロマトグ
ラフ法あるいは可視・紫外分光高度計にて分析定量し
た。 尿素の分離実験 0.025mol/リットルの濃度の尿素水溶液1ml
に、得られた高分子10mgを添加し、時々振とうしな
がら1時間20℃に保った。この後ポリマーを遠心分離
により除去して上澄み液を採取した。これにp−ジメチ
ルベンズアルデヒド塩酸塩の水溶液を加えることで発色
させ、430nmの吸光度より尿素の濃度を定量した。Separation Experiment of Nucleic Acid Derivatives 1 mg of the obtained polymer was added to 1 ml of an aqueous solution (pH 5 to 8) of various nucleic acid derivatives having a concentration of 1.0 × 10 −4 mol / liter, and 1 The temperature was kept at 20 ° C. After that, the polymer was removed by centrifugation, and the concentration of the remaining nucleic acid derivative in the supernatant was analyzed and quantified by the reversed phase high performance liquid chromatography method or the visible / ultraviolet spectrophotometer. Urea separation experiment 1 ml of urea aqueous solution with a concentration of 0.025 mol / liter
Then, 10 mg of the obtained polymer was added, and the mixture was kept at 20 ° C. for 1 hour with occasional shaking. After this, the polymer was removed by centrifugation and the supernatant was collected. Color was developed by adding an aqueous solution of p-dimethylbenzaldehyde hydrochloride thereto, and the concentration of urea was quantified from the absorbance at 430 nm.
【0017】 [0017]
【0018】表に示すように、本発明の高分子Aおよび
Bは核酸誘導体および尿素に対して明らかな吸着活性を
示した。更に驚くべきことに本発明の高分子Aは尿酸に
対して非常に高い活性を示し、水溶液中のすべての尿酸
が高分子Aに吸着された。一方、中空糸の原料として用
いられるセルロースは、核酸誘導体に対して有意な吸着
活性を示さなかった。As shown in the table, the polymers A and B of the present invention showed a clear adsorption activity for the nucleic acid derivative and urea. Further, surprisingly, the polymer A of the present invention showed very high activity against uric acid, and all the uric acid in the aqueous solution was adsorbed on the polymer A. On the other hand, cellulose used as a raw material for hollow fibers did not show significant adsorption activity for nucleic acid derivatives.
【0019】[実施例2]水の代わりにメタノールを溶
媒として用いる事以外は、実施例1と同様にして核酸お
よび尿素の分離実験を行った。その結果、高分子AとB
はメタノール中でも尿素および核酸塩基誘導体を効率良
く除去した。Example 2 An experiment for separating nucleic acid and urea was conducted in the same manner as in Example 1 except that methanol was used as a solvent instead of water. As a result, polymers A and B
Efficiently removed urea and nucleobase derivatives even in methanol.
【0020】[実施例3]水の代わりにエタノールを溶
媒として用いる事以外は、実施例1と同様にして核酸お
よび尿素の分離実験を行った。その結果、高分子AとB
はメタノール中でも尿素および核酸塩基誘導体を効率良
く除去した。[Example 3] A separation experiment for nucleic acid and urea was carried out in the same manner as in Example 1 except that ethanol was used as a solvent instead of water. As a result, polymers A and B
Efficiently removed urea and nucleobase derivatives even in methanol.
【本発明の効果】以上の様に、本発明の高分子材料を用
いることにより核酸誘導体および尿素が親水性溶媒中か
ら効率よく除去された。As described above, the nucleic acid derivative and urea were efficiently removed from the hydrophilic solvent by using the polymer material of the present invention.
【図1】 本発明の高分子材料中に導入されている残基
と、核酸誘導体あるいは尿素の結合様式の模式図であ
る。FIG. 1 is a schematic diagram of a binding mode between a residue introduced into a polymer material of the present invention and a nucleic acid derivative or urea.
【図2】 本発明で導入可能な残基の例である。FIG. 2 is an example of residues that can be introduced in the present invention.
─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───
【手続補正書】[Procedure amendment]
【提出日】平成8年9月30日[Submission date] September 30, 1996
【手続補正2】[Procedure amendment 2]
【補正対象書類名】図面[Document name to be amended] Drawing
【補正対象項目名】全図[Correction target item name] All figures
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【図1】 FIG.
【図2】 [Fig. 2]
フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C08G 69/48 NRH C08G 69/48 NRH Continuation of front page (51) Int.Cl. 6 Identification code Office reference number FI Technical display area C08G 69/48 NRH C08G 69/48 NRH
Claims (3)
吸着除去可能な高分子材料において、該高分子材料が式
(1)に示すような残基を有することを特徴とする高分
子材料 ここで X1、X2=N、CH Y=H、NHR2 R1、R2=H、アルキル基、フェニル基、アシル基 を示す。1. A polymeric material capable of adsorbing and removing a nucleic acid derivative and urea in a hydrophilic solvent, wherein the polymeric material has a residue as shown in formula (1). Here, X 1 , X 2 = N, CH Y = H, NHR 2 R 1 , R 2 = H, an alkyl group, a phenyl group, and an acyl group are shown.
特徴とする請求項1記載の高分子材料2. The polymer material according to claim 1 , wherein R 1 in the formula 1 is H.
ル、または水であることを特徴とする請求項1および請
求項2記載の高分子材料3. The polymer material according to claim 1 or 2, wherein the hydrophilic solvent is ethanol, methanol, or water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15596696A JPH09302034A (en) | 1996-05-14 | 1996-05-14 | Polymeric material which can remove nucleic acid derivative and urea by adsorption |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15596696A JPH09302034A (en) | 1996-05-14 | 1996-05-14 | Polymeric material which can remove nucleic acid derivative and urea by adsorption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH09302034A true JPH09302034A (en) | 1997-11-25 |
Family
ID=15617438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15596696A Pending JPH09302034A (en) | 1996-05-14 | 1996-05-14 | Polymeric material which can remove nucleic acid derivative and urea by adsorption |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH09302034A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6383783B1 (en) | 1999-09-21 | 2002-05-07 | 3M Innovative Properties Company | Nucleic acid isolation by adhering to hydrophobic solid phase and removing with nonionic surfactant |
| US6861473B2 (en) | 2003-02-28 | 2005-03-01 | Baxter International Inc. | Macromolecular ketoaldehydes |
-
1996
- 1996-05-14 JP JP15596696A patent/JPH09302034A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6383783B1 (en) | 1999-09-21 | 2002-05-07 | 3M Innovative Properties Company | Nucleic acid isolation by adhering to hydrophobic solid phase and removing with nonionic surfactant |
| US6861473B2 (en) | 2003-02-28 | 2005-03-01 | Baxter International Inc. | Macromolecular ketoaldehydes |
| US7544737B2 (en) | 2003-02-28 | 2009-06-09 | Baxter International Inc. | Macromolecular ketoaldehydes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69034213T2 (en) | UNLOADED MORPHOLIN-BASED POLYMERS WITH CHIRAL, PHOSPHOROUS BRIDGES BETWEEN THE SUB-UNITS | |
| CA1122208A (en) | Adsorbent for the affinity-specific separation of macromolecular materials | |
| US11384105B2 (en) | Processes for preparing oligomers | |
| EP0592434B1 (en) | Improved process for the synthesis of oligomers | |
| US5723599A (en) | Organic polymer reagents for solid phase synthesis of oligonucleotides | |
| CN101914099A (en) | Conjugates of Covalently Attached Oligonucleotides and Minor Groove Binders | |
| EP3469009B1 (en) | Solid support | |
| JPH10257888A (en) | Polyether nucleic acid | |
| Skakuj et al. | Mercury-free automated synthesis of guanidinium backbone oligonucleotides | |
| CN109661233A (en) | The method that oligomeric compound is conjugated | |
| Kuzmich et al. | Specifically alkylated DNA fragments. Synthesis and Physical Characterization of D [cGC (o 2 Me) GCG] and d [cGT (O 6 Me) GCG] | |
| EP1954671A1 (en) | Polynucleotide labelling reagent | |
| CN118103384A (en) | Solution Phase Polymer Synthesis | |
| US7157603B2 (en) | Method for the separation of oligomeric N-substituted (meth)acrylamide compounds and conjugates thereof which are reversibly thermally precipitating | |
| KR20040065994A (en) | Processes of purifying oligonucleotides | |
| EP4495165A1 (en) | Method for producing polyethylene glycol derivative | |
| CA1131225A (en) | Dyestuffs as affine residues | |
| WO1993023570A1 (en) | Oligonucleotides having conjugates attached at the 2'-position of the sugar moiety | |
| WO1999036429A2 (en) | Nucleobase oligomers | |
| WO2025056387A1 (en) | A support material for solid-phase synthesis of oligonucleotides and peptides | |
| WO2017222402A1 (en) | Polybenzimidazole polymer with e'unctionalized spacer chain and its method of preparation for removal of genotoxic impurities | |
| Bandik | The chemical synthesis of oligodeoxyribonucleotides | |
| WO1992003127A1 (en) | Compositions and methods for treating hiv infections | |
| JPS5850621B2 (en) | Polyion complexes | |
| Gao | Synthesis and characterization of oligonucleotides containing (15) N (1)-deoxyadenosine or 6-substituted deoxyguanosine |